Koushanpharmed Co.

What Koushanpharmed Co. does

Koushanpharmed Co. (شرکت داروسازی کوشان فارمد) is a private, knowledge-based pharmaceutical manufacturer established in 2008 (Iranian year 1387) as a subsidiary under Iranian conglomerate Ahraran Tejarat (اهران تجارت). The company is headquartered in Tehran, Iran, on Africa Boulevard, and self-positions as a leader in the treatment of respiratory diseases in Iran. Its therapeutic focus spans respiratory, cardiovascular, endocrine, and digestive conditions, with secondary lines in natural supplements, cosmetics, pharmaceutical supplies, and medical equipment distribution.

The company's core product portfolio combines branded prescription pharmaceuticals and proprietary herbal supplements. Notable products include DuoPect-Fort, a 100% herbal cough syrup combining Coptis rhizoma extract (berberine) and Ivy leaf extract (Hedera helix) approved under European Pharmacopoeia standards; Livomarin, a silymarin liver support supplement using Phosphocomplex® phytosome technology that claims up to 10x improved bioavailability versus silymarin alone; Multi Daily Glow, a collagen-based skin nutrition supplement; and Dipamidase, a cardiovascular drug launched at a 2024 cardiology congress. The underlying technology centers on proprietary formulation and bioavailability enhancement rather than novel chemical entities, with the company emphasizing R&D and creative combination of plant-derived actives.

Koushanpharmed operates a sales-led B2B GTM motion exclusively in Iran, distributing through pharmacy networks, hospitals, and healthcare institutions, supplemented by direct e-commerce via the company website for supplements and a content marketing presence through its health blog and social channels (Instagram, LinkedIn, WhatsApp, Telegram, Aparat). The company also engages in medical congress participation (Iranian Pharmacists Association, Heart Failure Congress, Pediatrics Congress, Internal Medicine Specialists Congress) and organizes Bridge cardiovascular disease prevention programs in cities including Mashhad and Shiraz to deepen specialist relationships. Pricing is not publicly disclosed and follows the regulated prescription-channel model typical of Iranian pharmaceuticals. No revenue, headcount, funding, or M&A disclosures are available in the source material.

Name

Koushanpharmed Co.

Legal name

Koushanpharmed Pharmaceutical Company (شرکت داروسازی کوشان فارمد)

Website

https://koushanpharmed.com

Company type

Private

Founded year

2008

Operating status

Operating

Short description

Koushanpharmed Co. is a private Iranian pharmaceutical manufacturer and subsidiary of Ahraran Tejarat, producing branded prescription drugs and herbal supplements for respiratory, cardiovascular, digestive, and endocrine conditions, distributed through pharmacies, hospitals, and direct e-commerce within Iran.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

akta.pro secondary industry

Respiratory & Allergy Pharmaceuticals (HLAIAAAH)

Keywords

• Pharmaceutical manufacturing
• Herbal cough syrups
• Natural dietary supplements
• Respiratory disease treatments
• Medical equipment supply

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Manufacturing and sale of pharmaceutical products including respiratory, cardiovascular, digestive, and endocrine medications. Revenue generated through direct sales to pharmacies, hospitals, and healthcare institutions in Iran.
2. Natural Supplements and Medicines: Production and sale of herbal-based supplements and natural medicines including cough syrups, liver support supplements, and nutritional supplements for skin health.
3. Medical Equipment and Pharmaceutical Supplies: Import and distribution of medical equipment and pharmaceutical supplies to healthcare facilities.
4. Cosmetics and Health Products: Production and sale of cosmetic and hygiene products.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Koushanpharmed Co. is an Iranian knowledge-based pharmaceutical manufacturer established in 2008 under the Ahraran Tejarat Group, focused on respiratory disease treatments. The company develops, manufactures, imports, and distributes branded pharmaceutical products, herbal-based natural supplements (cough syrups, liver support, skin nutrition), pharmaceutical supplies, cosmetics, and medical equipment through pharmacy networks, hospitals, and healthcare institutions in Iran.

Product overview

Koushanpharmed Co. is a knowledge-based pharmaceutical company established in 1387 (2008) under Ahraran Tejarat Group, specializing in respiratory disease treatments in Iran. The company operates as both an importer and manufacturer of pharmaceutical products, focusing on research and development for high-quality medicinal products. Their product portfolio includes branded pharmaceutical products (cardiovascular, glands, digestive, respiratory therapeutics), natural supplements (DuoPect Forte cough syrup, Livamarine liver supplement, Multi Daily Glow skin supplement), pharmaceutical supplies, cosmetics, and medical equipment. The company positions itself as a leader in respiratory medications, with specific branded products like DuoPect Forte (herbal cough syrup), Livamarine (liver protection), and Multi Daily Glow (nutritional supplement for skin health), alongside their broader pharmaceutical and medical supply categories.

Differentiator

Problem solved

Functional benefit

Brands

• DuoPect Forte (دوئوپکت فورت): 100% herbal cough syrup containing Coptis rhizoma extract and Ivy leaf extract, used as an expectorant and anti-inflammatory for acute respiratory infections and chronic bronchitis.
• Livomarin (لیوی مارین)
• Multi Daily Glow (مولتی دیلی گلو)

Products and services

• DuoPect Forte (دوئوپکت-فورت) 100% herbal cough syrup combining Coptis rhizoma extract (containing berberine with anti-inflammatory and antibacterial properties) and Ivy leaf extract (Hedera helix with expectorant and bronchodilator properties). Used as an expectorant, anti-inflammatory, and cough suppressant for acute respiratory infections and chronic bronchitis; approved against European Pharmacopoeia standards.
• Livomarin (لیوی مارین) Oral supplement containing Silymarin (Silybin) complexed with phospholipid (Phosphatidylcholine) as Phosphocomplex phytosome, designed to improve liver health and function. Reported to deliver up to 10x better absorption than silymarin alone and used for liver protection and fatty liver disease.
• Multi Daily Glow (مولتی پلاس دیلی گلو) Nutritional supplement containing collagen, white tea extract, pomegranate extract, grape extract, and lycopene, designed to support skin health, increase collagen production, and reduce wrinkles.
• Pharmaceutical Products (فرآورده‌های دارویی) Branded pharmaceutical product range across cardiovascular, endocrine (glands), digestive, respiratory, and general therapeutic categories, sold through pharmacy networks and healthcare institutions in Iran.
• Natural Supplements and Medicines (مکمل‌ها و داروهای طبیعی) Herbal and natural health supplements and medicines addressing a range of health conditions, distributed via pharmacies and the company website.
• Pharmaceutical Supplies (ملزومات دارویی) Pharmaceutical supplies and medical consumables distributed to pharmacies and healthcare facilities in Iran.
• Medical Equipment (تجهیزات پزشکی) Medical equipment and devices imported and distributed to hospitals and healthcare institutions in Iran.
• Cosmetics and Health Products (فرآورده‌های آرایشی و بهداشتی) Cosmetic and personal hygiene products manufactured and sold by Koushanpharmed in the Iranian market.

Quantifiable outcome

• DuoPect-Fort shown to reduce cough severity and duration in clinical studies involving both children and adults
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Ahraran Tejarat (اهران تجارت)coreOthers · 1 January 1387Koushanpharmed was established in 1387 under the parent company Ahraran Tejarat Group. As a subsidiary, the company operates under the umbrella of this larger commercial group, benefiting from shared resources, market reach, and organizational infrastructure.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Cipla: Indian global pharmaceutical company with leading respiratory, OTC and consumer-health franchises. Highly comparable in respiratory specialty leadership and pharmacy-channel go-to-market, though operating at vastly larger scale and geographic reach.
• Aurobindo Pharma: Indian global generics and specialty pharma manufacturer with broad respiratory and metabolic franchise and emerging-markets focus. Comparable scale-ambition trajectory and therapeutic-area breadth to Koushanpharmed's aspiration.
• Hikma Pharmaceuticals: Jordan-headquartered multinational with broad generics, branded and injectable portfolios sold across MENA, US and Europe. Overlaps with Koushanpharmed's branded multi-therapeutic-area positioning but at far greater geographic and capital scale.
• Dr. Reddy's Laboratories: Indian-headquartered multinational pharmaceutical company with branded generics across cardiovascular, respiratory and metabolic therapy areas. Comparable in diversified therapeutic-area branded pharma and emerging-markets distribution muscle.
• Darou Pakhsh Pharma: One of the largest Iranian pharmaceutical manufacturers with broad generics and specialty products across respiratory and metabolic therapies. Comparable therapeutic-area mix and Iranian market, but operates at much greater scale than Koushanpharmed.

Direct peers

• Julphar (Gulf Pharmaceutical Industries): UAE-based MENA pharmaceutical manufacturer with branded generics, OTC and consumer-health products distributed across GCC pharmacy networks. Directly comparable business model (multi-therapeutic-area branded pharma + supplements) operating in a similar regional healthcare channel.
• CinnaGen: Iranian biotech/pharmaceutical manufacturer with branded specialty products across multiple therapeutic areas sold through the same domestic pharmacy channel. Directly comparable in operating geography, channel mix, and branded specialty positioning.

Others

• Cipla Consumer (related OTC supplements player): Indian pharmaceutical major with strong OTC and natural-supplement adjacencies in respiratory and wellness categories. Comparable as a reference point for how a branded respiratory/specialty pharma extends into consumer herbal supplements.

Regional players

• Tabuk Pharmaceuticals: Saudi pharmaceutical manufacturer with branded generics across cardiovascular, respiratory and metabolic therapies. Similar therapeutic-area breadth and OTC positioning to Koushanpharmed but based in Saudi Arabia with a GCC go-to-market.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Saudi-listed pharma manufacturer with branded generics and licensed products distributed across MENA. Comparable in being a regional branded-specialty player but operates from Saudi Arabia rather than Iran and at greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/koushan-pharmed

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Koushanpharmed Co.